Peijia Medical and HighLife enter license agreement for mitral valve replacement in Greater China

Peijia Medical and HighLife SAS entered into a license agreement granting Peijia an exclusive license to manufacture, develop, and commercialize HighLife's TMVR products in Greater China, with upfront fee and milestone payments.

“Peijia Medical Ltd and HighLife SAS announced that they have entered into a license agreement pursuant to which HighLife has granted to Peijia an exclusive license regarding certain proprietary TMVR products currently in development by the Licensor.”sofinnovapartners.com

• 1 source
• sofinnovapartners.comPeijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China — Sofinnova PartnersDec 21, 2020

Summarized from public sources; check the original articles before acting on it.